市場調查報告書
商品編碼
1390402
腸促胰島素相關藥物的全球市場:按藥物類型、給藥途徑、適應症、地區和國家、市場考察和預測進行分析Global Incretin Based Drugs Market : Analysis By Drug Type, Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast |
全球腸促胰島素相關藥物市場規模預計將從2022年的 407.2 億美元增至2029年終的 642.8 億美元,2024-2029年預測期間年複合成長率為 6.8%。
全球 2 型糖尿病盛行率的不斷上升對腸促胰島素相關藥物的需求產生了重大影響。糖尿病盛行率的增加是由多種因素造成的,包括久坐的生活方式、不良的飲食習慣和高齡化。
與許多其他抗高血糖藥物相比,腸促胰島素相關藥物具有幾個顯著的優點,包括沒有低血糖或體重增加的風險。 DPP4I和GLP-1RA表現出獨特的療效和耐受性,使醫生能夠考慮疾病狀況(以HbA1c百分比表示)、體重以及患者對自行注射藥物的偏好等因素,為患者選擇最合適的藥物每個病人。隨著學名藥和給藥減少的改進配方的推出,市場上的重磅藥物變得可用,腸促胰島素相關藥物的需求預計將呈指數級成長。
本報告調查全球腸促胰島素相關藥物市場,並提供了包括市場規模和預測、區域和細分市場分析以及主要趨勢和機會在內的資訊。
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), By Route of Administration (Oral, Injectables) and By Indication (Diabetes, Obesity) for the historical period of 2018-2022, the estimated year of 2023 and the forecast period of 2024-2028.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Incretin Based Drugs market is expected to grow at a CAGR of 6.8%. The Global Incretin Based Drugs Market is expected to generate USD 64.28 billion by the end of 2029, up from USD 40.72 Billion in 2022.
Incretin-based drugs are the first-of-its-kind anti-hyperglycemic medications that have been developed by specifically targeting a recognized pathophysiological abnormality in type 2 diabetes. The global increase in the prevalence of type 2 diabetes has a significant impact on the demand for incretin-based drugs. The growing incidence of diabetes can be attributed to various factors, including sedentary lifestyles, poor dietary habits, and the ageing demographic.
In comparison to many other anti-hyperglycemic medications, incretin-based drugs offer some notable benefits, including the lack of an elevated risk of hypoglycemia or weight gain. The DPP4Is and GLP-1RAs exhibit unique efficacy and tolerability profiles, providing physicians with the opportunity to choose the most suitable medication for each patient, taking into account factors such as disease status (as indicated by HbA1c percentage), body weight, and patient preference for self-administered injectable drugs. The demand for Incretin-based drugs is expected to grow exponentially as the blockbuster drugs in the market become accessible in generic form and as upgraded formulations with reduced dosing frequency are introduced.
List of Tables
Table A1: Incretin based drugs in Several stages of clinical trials
Table A2: United States Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A3: United States Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A4: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A5: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A6: United States Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A7: United States Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A8: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A9: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A10: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A11: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A12: Canada Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A13: Canada Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A14: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A15: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A16: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A17: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A18: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A19: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A20: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A21: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A22: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A23: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A24: Germany Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A25: Germany Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A26: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A27: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A28: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A29: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A30: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A31: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A32: France Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A33: France Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A34: France Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A35: France Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A36: France Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A37: France Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A38: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A39: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A40: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A41: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A42: Italy Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A43: Italy Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A44: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A45: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A46: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A47: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A48: Spain Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A49: Spain Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A50: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A51: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A52: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A53: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A54: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A55: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A56: China Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A57: China Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A58: China Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A59: China Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A60: China Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A61: China Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A62: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A63: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A64: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A65: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A66: Japan Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A67: Japan Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A68: India Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A69: India Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A70: India Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A71: India Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A72: India Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A73: India Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A74: Rest of Asia Pacific Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)
Table A75: Rest of Asia Pacific Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)
Table A76: Rest of Asia Pacific Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)
Table A77: Rest of Asia Pacific Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)
Table A78: Rest of Asia Pacific Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)
Table A79: Rest of Asia Pacific Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)
Table A80: Eli Lilly and Company Key Financials, 2020-2022
Table A81: Novo Nordisk Key Financials, 2020-2022
Table A82: AstraZeneca PLC Key Financials, 2020-2022
Table A83: Merck & Co., Inc. Key Financials, 2020-2022
Table A84: Pfizer Key Financials, 2020-2022
Table A85: Novartis Key Company Financials, 2020-2022
Table A86: Takeda Pharmaceuticals Key Financials, 2020-2022
Table A87: Bristol-Myers Squibb Key Financials, 2020-2022